arrow_back Trending Legislation
Share share

New PTSD therapy for veterans and service members

This act introduces a new treatment option for post-traumatic stress disorder (PTSD) for veterans and active service members, providing access to stellate ganglion block. This means individuals suffering from PTSD will have a broader range of therapies available, potentially improving their quality of life and daily functioning. These changes aim to ensure better healthcare for those who have served the country.
Key points
Veterans and service members with PTSD will gain access to a new therapy, stellate ganglion block, if they choose it after being informed of its risks and benefits.
The Department of Veterans Affairs and the Department of Defense must update their PTSD treatment guidelines to include this new option.
The act aims to expand available treatment methods for individuals suffering from PTSD, potentially bringing relief and improving mental health.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
TREAT PTSD Act
Print number: HR 3023
Sponsor: Rep. Perry, Scott [R-PA-10]
Process start date: 2023-04-28
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about New PTSD therapy for veterans and service members

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 3023.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-04-28.

What are the main provisions?

Key points include:

  • Veterans and service members with PTSD will gain access to a new therapy, stellate ganglion block, if they choose it after being informed of its risks and benefits.
  • The Department of Veterans Affairs and the Department of Defense must update their PTSD treatment guidelines to include this new option.
  • The act aims to expand available treatment methods for individuals suffering from PTSD, potentially bringing relief and improving mental health.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Perry, Scott [R-PA-10].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 3023

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Benefits